East Coastsentinel

Staying informed about the latest news and press releases is paramount for successful trading and investing. These timely updates offer valuable insights into market trends, emerging opportunities, and noteworthy developments across industries. By actively tracking news and announcements, traders can make well-informed decisions and capitalize on potential opportunities. 

Yesterday, several companies shared significant press releases, highlighting the critical role of staying abreast of such information in navigating the dynamic world of trading. Let’s take a deeper dive into a few of those announcements from yesterday.

Epazz Inc. (OTC: EPAZ) is an emerging provider of drone technology and blockchain-based business solutions. On July 19, EPAZ announced a significant collaboration with CryObo Technology to tokenize crops through the issuance of Non-Fungible Tokens (NFT). This partnership aims to empower farmers by providing them with an opportunity to generate extra revenue by leveraging their agricultural produce.

A recent court decision in favor of Ripple has paved the way for US farmers to benefit from CryObo technology without the need for registration statements. EPAZ will issue tokens to customers in compliance with the court’s decision. CryObo software allows farmers to tokenize farm crops and produce, allowing them to raise immediate capital based on future milestones. Token holders can evaluate the token’s income, allowing them to participate in the success of tokenized crop production and produce.

EPAZ’s integration of ZenaDrone 1000 technology with the CryObo tokenization system represents a significant development. The ZenaDrone 1000, equipped with advanced aerial data technology, allows farmers to scan fields and accurately assess crop health, resulting in improved predictions of harvest yield. This information empowers farmers to make informed decisions regarding irrigation, fertilization, and weed control, leading to enhanced productivity during the growing season.

The issuance of NFT tokens expands Epazz’s market reach and provides opportunities for farm owners, plantation associations, and agricultural business investors to participate in the tokenized crop production and produce. Token holders will receive a share in the income generated from the tokenization process, making it an attractive investment opportunity in the agricultural sector.

In addition to crop tokenization, Epazz’s CryObo technology utilizes solar power for sustainable Bitcoin mining and employs NFT tokens for farmland tokenization. The company demonstrates its commitment to sustainable energy by developing cooling technology for underground servers.

Shaun Passley, Ph.D., Epazz Inc.’s CEO and Chairman, emphasized the significance of this collaboration, stating, “Forward cash contracts have been used in the farming business for decades. We are essentially integrating ZenaDrone technology with the CryObo tokenization system to achieve a transparent open ledger digitization of these forward cash contracts, which facilitates expanded access to farm investing.”

EPAZ’s partnership with CryObo Inc. positions the company as a disruptor in various sectors, enabling early-access companies with tangible assets to easily access token markets. CryObo Inc.’s platform transforms the way real estate, digital assets, crops, and raw materials are transacted, offering a smart solution for managing growing portfolios in the face of evolving cryptocurrency regulations.

Sidus Space, Inc. (NASDAQ: SIDU) is a Space and Defense-as-a-Service satellite company specializing in various services within the space industry. Based in Cape Canaveral, Florida, Sidus Space operates from a state-of-the-art facility focused on commercial satellite design, manufacturing, launch, and data collection. The company has built a strong reputation over the past decade, serving clients such as international and US governments, NASA, and major space and defense prime contractors like Parsons Corporation.

On July 19, Sidus Space announced they had secured a subcontract from Parsons Corporation (NYSE: PSN) for US Space Force Launch Manifest Systems Integration (LMSI) support. This partnership highlights Sidus Space’s position as a key player in the space community and its growing role as a trusted manufacturing partner for prime contractors involved with the US Space Force.

Under the subcontract agreement, Sidus Space will fabricate a master harness assembly and test cables for Parsons, further cementing its expertise in manufacturing mission-critical hardware. With a strong track record of success and space qualification know-how, Sidus Space plays a crucial role in missions beyond low Earth orbit, including destinations like the moon and Mars.

Parsons Corporation, as the prime contractor for the US Space Force’s LMSI, is responsible for integrating and operating rideshare payloads for national security and other US government missions. Their extensive experience includes the successful integration of payloads for notable missions, such as the US Space Force’s Advanced Extremely High Frequency (AEHF)-5 communications satellite and the joint NASA/US Geological Survey Landsat 9 Earth observation satellite.

Sidus Space’s mission of “Bringing Space Down to Earth” is focused on enabling space flight heritage status for new technologies while delivering valuable data and predictive analytics to domestic and global customers. The company offers a comprehensive range of Space-As-a-Service solutions, including hardware manufacturing, design engineering, satellite manufacturing, launch services, data analytics, and satellite constellation management.

By combining its expertise with the opportunity to collaborate with Parsons on the US Space Force’s LMSI support, Sidus Space demonstrates its commitment to playing a significant role in advancing space technology and supporting critical space missions.

Quad M Solutions (OTC: MMMM) has made a significant announcement regarding its subsidiary, QM Racing. The company has successfully acquired REV Technologies, a prominent race-to-road electrification technology company. This strategic acquisition grants QM Racing ownership rights to the highly anticipated Riley Streetfighter, a cutting-edge three-wheeled electric vehicle currently being developed in collaboration with Riley Technologies, based in North Carolina.

The Riley Streetfighter boasts impressive features such as 0–60 mph acceleration in under three seconds, a range of up to 200 miles per charge, and a customizable price range. QM Racing aims to redefine the powersports market by offering best-in-class performance and sustainability through this innovative electric vehicle.

By leveraging Riley’s expertise and production facilities, QM Racing plans to scale up Streetfighter production in the near future. The company recognizes the substantial growth potential in the electric three-wheeler market, which is projected to nearly double in the next decade and surpass the $1.5 billion mark by 2033, according to Future Market Insight.

This acquisition allows QM Racing to take advantage of Riley’s development expertise and existing production facilities, minimizing upfront capital spending on design and manufacturing infrastructure. With 90 percent of the Streetfighter components being vertically manufactured in-house at Riley’s Mooresville facility, QM Racing aims to rapidly scale up production while reducing costs compared to competitors.

The highly anticipated Streetfighter could revolutionize the electric vehicle industry and deliver a thrilling driving experience to customers across the nation. QM Racing, a wholly owned subsidiary of Quad M Solutions, is dedicated to delivering high-performance electric vehicles that combine cutting-edge technology with a passion for automotive excellence.

Aptevo Therapeutics Inc. (Nasdaq: APVO), a clinical-stage biotechnology company focused on developing immuno-oncology therapies for cancer, has announced positive results from its Phase 1b expansion trial for acute myeloid leukemia (AML). In combination with standard treatments, APVO436 achieved a high response rate, with patients experiencing sustained remission and successful transplants.

Based on these encouraging results, Aptevo is updating its Phase 2 program, which will evaluate APVO436 in combination with other therapies for frontline and relapsed or refractory AML patients. The company plans to initiate trials in the second half of 2023 and expects interim results in late 2024.

APVO436 has shown a 91% clinical benefit when combined with standard treatments and has demonstrated a good safety profile. Aptevo’s focus on safety, tolerability, efficacy, and durability reinforces the potential of APVO436 as a combination therapy for AML patients.

As a clinical-stage biotechnology company, Aptevo is dedicated to improving treatment outcomes for cancer patients. APVO436, a bispecific drug candidate, redirects the immune system to target leukemia cells expressing the CD123 molecule. This update marks a significant step forward in the development of APVO436 and showcases Aptevo’s commitment to advancing novel immuno-oncology therapies.

Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. ‘CGR’  is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.

Media Contact
Company Name: Capital Gains Report
Contact Person: Mark McKelvie
Email: Send Email
City: NAPLES
State: FLORIDA
Country: United States
Website: https://capitalgainsreport.com/